ETNB NASDAQ
89bio, Inc.
1W: +0.3%
1M: +1.0%
3M: +62.0%
1Y: +85.0%
3Y: +69.8%
5Y: -39.3%
$14.84
Last traded 2025-10-30 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$38K
+86.1% ▲
Operating Income
-$385M
-154.4% ▼
Net Income
-$367M
-158.2% ▼
EPS (Diluted)
$-3.51
-75.5% ▼
EBITDA
-$385M
-186.1% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $60K | $79K | $240K | $273K | $38K |
| Gross Profit | -$60K | -$79K | -$240K | -$273K | -$38K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $36M | $70M | $81M | $122M | $345M |
| SG&A Expenses | $13M | $19M | $21M | $29M | $40M |
| Operating Expenses | $49M | $90M | $102M | $151M | $385M |
| Operating Income | -$49M | -$90M | $102M | -$151M | -$385M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $674K | $2M | $4M | $4M |
| Income Before Tax | -$50M | -$90M | -$102M | -$138M | -$366M |
| Tax Expense | -$59K | -$147K | $19K | $4M | $692K |
| Net Income | -$49M | -$90M | -$102M | -$142M | -$367M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-3.08 | $-4.48 | $-2.93 | $-2.00 | $-3.51 |
| EBITDA | -$49M | -$90M | -$100M | -$134M | -$385M |
| Shares Outstanding | 16M | 20M | 35M | 71M | 105M |